-
Sector Analysis
DBGS and Regenerative Materials Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
DBGS and Regenerative Materials Market Report Overview The DBGS and Regenerative Materials market size was valued at $508.1 million in 2023. Factors such as the changing attitude toward dentistry and improved reimbursement by governments will drive the market growth. Thus, the DBGS and Regenerative Materials market is expected to grow at a CAGR of more than 4% during 2023-2033. Dental Bone Graft is used to augment or fill a defect created by surgery, trauma, disease, and developmental deficiency. On the...
-
Sector Analysis
NewAutomotive Braking Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Braking Systems Market Report Overview The automotive braking systems market size was 578.5 million units in 2023. The market will grow at a CAGR of more than during 2023-2028. Rapid growth in EV adoption is driving the demand for regenerative braking systems. In 2023, Asia-Pacific accounted for a significant share of the automotive braking systems market. Automotive Braking Systems Market Outlook, 2023-2028 (Million Units) Buy the Full Report for More Insights on the Automotive Braking Systems Market Report Forecast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBT-NPC in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBT-NPC in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBT-NPC in Parkinson's Disease Drug Details: CBT-NPC is under development for the...
-
Track & Monitor
Innovation in automotive: Regenerative braking
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Regenerative braking segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...
-
Product Insights
NewHyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Product Insights
NewArtificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
Osteonecrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Osteonecrosis - Drugs In Development, 2023’, provides an overview of the Osteonecrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteonecrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Premature Ovarian Failure – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Ovarian Failure - Drugs In Development, 2023’, provides an overview of the Premature Ovarian Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Ovarian Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.